-
公开(公告)号:US20240182431A1
公开(公告)日:2024-06-06
申请号:US18278750
申请日:2022-03-14
Applicant: Bayer Aktiengesellschaft
Inventor: Thomas BRUMBY , Jessica LOHRKE , Simon Anthony HERBERT , Olaf PANKNIN , Thomas FRENZEL , Claudia GREEN , Gregor JOST , Hubertus PIETSCH , Markus BERGER , Sven WITTROCK
IPC: C07D257/02 , A61K49/08 , C07F5/00
CPC classification number: C07D257/02 , A61K49/085 , C07F5/003
Abstract: The present invention relates to a new class of compounds of general formula (I), the Gd3+ chelate complexes thereof, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents. Formula (I)
-
公开(公告)号:US20250064060A1
公开(公告)日:2025-02-27
申请号:US18706810
申请日:2022-11-02
Inventor: Mazen ES-SAYED (DECEASED) , Lionel NICOLAS , Julie GEIST , Cyril MONTAGNE , Anthony MILLET , Mathieu GOURGUES , Dominique LOQUE , Vincent THOMAS
IPC: A01N43/58 , A01N43/40 , A01N43/42 , A01N43/54 , A01N43/707 , A01P3/00 , C07D213/81 , C07D215/50 , C07D237/24 , C07D237/28 , C07D239/38 , C07D253/07
Abstract: The present invention relates to Bis(hetero)aryl thioether (thio)amides derivatives and the uses thereof for controlling phytopathogenic microorganisms such as phytopathogenic fungi. It also relates to processes and intermediates for preparing these compounds.
-
公开(公告)号:US20250057164A1
公开(公告)日:2025-02-20
申请号:US18719447
申请日:2022-12-13
Applicant: BAYER AKTIENGESELLSCHAFT
Inventor: Lothar LORENTZ , Dirk EBBINGHAUS , Roland Franz DECKWER , Klaus NUTTELMANN , Matthias HAAS , Volker KÜHNHOLD , Thomas Alexander SMIT , Herve TOSSENS
Abstract: The invention relates to the field of food storage, more specifically to the use of methyl(2R*,4R*)-4-[[(5S)-3-(3,5-difluorophenyl)-5-vinyl-4H-isoxazole-5-carbonyl]amino]tetrahydrofuran-2-carboxy-late (I) for sprout inhibition in crops, the use of combinations or compositions comprising thereof for sprout inhibition in crops and a method for controlling sprouts on crops.
-
公开(公告)号:US20250049788A1
公开(公告)日:2025-02-13
申请号:US18726374
申请日:2023-01-05
Applicant: Bayer Aktiengesellschaft
Inventor: Martina DELBECK , Michael HAHN
IPC: A61K31/496 , A61K45/06 , C07D405/14 , C07D417/14
Abstract: The present invention relates to α2-Adrenoceptor subtype C (alpha-2C) antagonists, in particular 2,3-Dihydrobenzo[b][1,4]dioxin-2-ylmethyl)piperazin-1-yl derivates of formula (I) for the use in a method for the treatment and/or prophylaxis of sleep-related breathing disorders, preferably obstructive and central sleep apneas and snoring.
-
公开(公告)号:US12221479B2
公开(公告)日:2025-02-11
申请号:US17416958
申请日:2019-12-12
Applicant: Bayer Aktiengesellschaft , Deutsches Krebsforschungszentrum
Inventor: Jörg Willuda , Mark Trautwein , Rienk Offringa , Hans-Henning Böhm , Philipp Beckhove
IPC: A61K39/395 , A61K45/06 , A61P35/00 , C07K16/28
Abstract: The present disclosure relates to combinations of at least two components, component A and component B, component A being anti-CEACAM6 antibody TPP-3310 and component B being an anti-TIM-3 antibody, preferentially cobolimab, MBG-453, BMS-986258, Sym-023, LY-3321367 or INCAGN-2390.
-
公开(公告)号:US20250040554A1
公开(公告)日:2025-02-06
申请号:US18717656
申请日:2022-12-08
Applicant: BAYER AKTIENGESELLSCHAFT , BAYER CROPSCIENCE LP
Inventor: Lothar LORENTZ , Sabine STOLZ , Volker KÜHNHOLD , Catherine Marie DE VULDER , Udo BICKERS , Herve TOSSENS , Andrea MAAS
Abstract: The present invention primarily relates to the (selective) use of phenmedipham in the crop plants corn, cotton and soybean, and to certain herbicidally active combinations or compositions comprising (A) phenmedipham and (B) one or more aroylcyclohexanedione herbicides. The invention further relates to the use of these combinations for controlling weeds, and to corresponding methods.
-
公开(公告)号:US12187705B2
公开(公告)日:2025-01-07
申请号:US17046365
申请日:2019-04-10
Applicant: Bayer Aktiengesellschaft
Inventor: Alexander Arlt , Werner Hallenbach , Hans-Georg Schwarz , Martin Fuesslein , Heinz-Juergen Wroblowsky , Marc Linka , Sascha Eilmus , Kerstin Ilg , Ulrich Goergens , Arunas Jonas Damijonaitis , Yolanda Cancho Grande , Ulrich Ebbinghaus-Kintscher , Peter Jeschke , Weijie Ha , Iring Heisler , Andreas Turberg
IPC: C07D403/04 , A01N43/653 , A01N55/00
Abstract: The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q1, Q2, R1, R2, R3a, R3b, R4 and R5 have the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.
-
8.
公开(公告)号:US12180187B2
公开(公告)日:2024-12-31
申请号:US17615786
申请日:2020-05-29
Applicant: BAYER AKTIENGESELLSCHAFT
Inventor: Michael Gerhard Hoffmann , Estella Buscato Arsequell , Harald Jakobi , Thomas Mueller , Erin Nicole Smith , Elisabeth Asmus , Anu Bheemaiah Machettira , Elmar Gatzweiler , Christopher Hugh Rosinger , Dirk Schmutzler
IPC: C07D403/04 , A01N43/54 , A01N43/56 , A01N43/60 , A01N43/78 , A01P13/02 , C07D401/04 , C07D401/14 , C07D405/14 , C07D417/14
Abstract: What are described are compounds of the general formula (I) and agrochemically acceptable salts thereof and their preparation and their use in the crop protection sector.
-
公开(公告)号:US12173068B2
公开(公告)日:2024-12-24
申请号:US18399934
申请日:2023-12-29
Applicant: BAYER AKTIENGESELLSCHAFT
Inventor: Dorian Schönfeld , Karoline Dröbner , Ernst Weber , Katharina Filarsky , Philipp Ellinger , Fionnuala Mary McAleese Eser , Ingo Flamme , Winfried Wunderlich , Antje Schmidt , Yalda Sedaghat , Kenneth Young
Abstract: The present disclosure relates to an isolated antibody or antigen-binding fragment thereof that binds to human Sema3A. The isolated antibody or antigen-binding fragment according to the present disclosure i) binds to human Sema3A of the sequence of SEQ ID NO: 600 with a dissociation constant (KD)≤50 nM, ≤20 nM, ≤10 nM, ≤1 nM, or ≤0.1 nM; ii) cross-reacts with mouse, cynomolgus, rat, pig and/or dog Sema3A, particularly wherein said isolated antibody or antigen-binding fragment thereof binds to mouse, cynomolgus, rat, pig and/or dog Sema3A with a dissociation constant (KD)≤50 nM, ≤20 nM, ≤10 nM, ≤1 nM, or ≤0.1 nM; iii) binds to human Sema3A of the sequence of SEQ ID NO: 600 with a binding activity as measured by surface plasmon resonance (SPR) of ≥60%, ≥70%, ≥80%, or ≥90%; iv) inhibits the activity of human Sema3A of the sequence of SEQ ID NO: 600 in an in vitro mesangial cell migration assay with an EC50 of ≤10 nM, ≤5 nM, ≤2.5 nM, or ≤1 nM; v) inhibits the activity of human Sema3A of the sequence of SEQ ID NO: 600 in an in vitro growth cone collapse assay with an EC50 of ≤50 nM, ≤25 nM, ≤10 nM, or ≤5 nM; vi) inhibits the activity of human Sema3A of the sequence of SEQ ID NO: 600 in an in vitro HUVEC repulsion assay with an EC50 of ≤1 nM, or ≤0.3 nM, ≤0.1 nM, ≤0.07 nM, ≤0.06 nM and/or vii) exhibits an increased potency against cellular Sema3A, of the sequence of SEQ ID NO: 600, induced HUVEC repulsion.
-
公开(公告)号:US20240404255A1
公开(公告)日:2024-12-05
申请号:US18678323
申请日:2024-05-30
Applicant: BAYER AKTIENGESELLSCHAFT
Inventor: Matthias LENGA , Ivo Matteo BALTRUSCHAT , Parvaneh JANBAKHSHI , Felix Karl KREIS
IPC: G06V10/774 , A61K49/10 , G06V10/82
Abstract: The present disclosure is concerned with the technical field of generation of artificial contrast-enhanced radiological images.
-
-
-
-
-
-
-
-
-